NKCs with significant antitumor activity via generating perforin and granzyme, have been reported to express receptors for targeting specific ligands on the tumor cells’ surface.[168] This fact has been an underlying reason for exploiting NKCs’ membrane to develop biomimetic drug delivery systems with improved tumor targeting and recruiting. Here, PRF1 is linked to neoplasm.